Zobrazeno 1 - 10
of 319
pro vyhledávání: '"Hosseinipour MC"'
Autor:
Hsieh, YL, Jahn, A, Menzies, NA, Yaesoubi, R, Salomon, JA, Girma, B, Gunde, L, Eaton, JW, Auld, A, Odo, M, Kiyiika, CN, Kalua, T, Chiwandira, B, Mpunga, JU, Mbendra, K, Corbett, L, Hosseinipour, MC, Cohen, T, Kunkel, A
BACKGROUND: To assist the Malawi Ministry of Health to evaluate two competing strategies for scale-up of isoniazid preventive therapy (IPT) among HIV-positive adults receiving ART. SETTING: Malawi. METHODS: We used a multi-district, compartmental mod
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1032::a6e6afad3f1d547dcfbb0a60c09ea61f
http://hdl.handle.net/10044/1/82915
http://hdl.handle.net/10044/1/82915
Autor:
Chen, T, Mwenge, L, Lakhi, S, Chanda, D, Mwaba, P, Molloy, SF, Gheorghe, A, Griffiths, UK, Heyderman, RS, Kanyama, C, Kouanfack, C, Mfinanga, S, Chan, AK, Temfack, E, Kivuyo, S, Hosseinipour, MC, Lortholary, O, Loyse, A, Jaffar, S, Harrison, TS, Niessen, LW, ACTA Trial Team
Background\ud Mortality from cryptoccocal meningitis remains high. The ACTA trial demonstrated that, compared with 2 weeks of amphotericin B (AmB) plus flucystosine (5FC), 1 week of AmB and 5FC was associated with lower mortality and 2 weeks of oral
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::ac8abe6ccc1d99ff9013e3820aedad89
https://openaccess.sgul.ac.uk/id/eprint/110685/6/ciy971.pdf
https://openaccess.sgul.ac.uk/id/eprint/110685/6/ciy971.pdf
Autor:
Haddad Lb, Ganesan R, Kinuthia J, Brahmi D, Ogutu O, Melanie Pleaner, Biraboneye Sp, Morisky De, Caughey Ab, Helen Rees, Healy J, Saiqa Mullick, Urada La, Tsuyuki K, Chaweza T, Jamieson Dj, Daisy Pillay, M. Makua, Wingston Ng’ambi, Gipson Jd, Gaffield Me, Krashin J, Tang Jh, Tweya H, Phiri S, Wanjala S, Regina Maria Barbosa, Benson J, van Roosmalen J, Lubano K, Matthew Chersich, Lathrop E, Andersen K, Naomi Lince-Deroche, Hosseinipour Mc, Smit J, Chelsea Morroni, Han L, Rodriguez Mi, Samala B, Jane Chiwoko, Edwards S
Publikováno v:
BMJ Sexual & Reproductive Health
BackgroundUnderstanding the influences on condom use among men and women living with HIV is critical to tailoring sexually transmitted infection/HIV prevention efforts.MethodsThis is a sub-analysis of a cross-sectional survey including 255 women and
Autor:
Jarvis, JN, Bicanic, T, Loyse, A, Namarika, D, Jackson, A, Nussbaum, JC, Longley, N, Muzoora, C, Phulusa, J, Taseera, K, Kanyembe, C, Wilson, D, Hosseinipour, MC, Brouwer, AE, Limmathurotsakul, D, White, N, van der Horst, C, Wood, R, Meintjes, G, Bradley, J, Jaffar, S, Harrison, T
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Cerebrospinal fluid fungal burden, altered mental status, and rate of clearance of infection predict acute mortality in HIV-associated cryptococcal meningitis. The identification of factors associated with mortality informs strategies to improve outc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::3165306458053a52e6cf5af2f09f0724
Autor:
Mhango, B, Kumwenda, JJ, Weigel, R, Brown, LB, Eron, JJ, Phiri, S, Hosseinipour, MC, Mzinganjira, D, van Oosterhout, JJ
The Malawi antiretroviral therapy (ART) programme uses the public health approach to identify ART failure. Advanced disease progression may occur before switching to second-line ART. We report outcomes for patients evaluated and initiated on second-l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3fd2997510167308bcfbc9267b6340a3
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Garrett N; Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa.; Department of Public Health Medicine, School of Nursing and Public Health, University of KwaZulu-Natal, Durban, South Africa., Dintwe O; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA.; Cape Town HVTN Immunology Laboratory, Cape Town, South Africa., Monaco CL; Department of Medicine, Division of Infectious Diseases, University of Rochester Medical Center, Rochester, NY.; Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, NY., Jones M; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA., Seaton KE; Center for Human Systems Immunology, Departments of Surgery, Molecular Genetics and Microbiology, and Immunology, Duke University School of Medicine, Durham, NC., Church EC; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA., Grunenberg N; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA., Hutter J; Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD., deCamp A; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA., Huang Y; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA., Lu H; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA., Mann P; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA., Robinson ST; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA., Heptinstall J; Center for Human Systems Immunology, Departments of Surgery, Molecular Genetics and Microbiology, and Immunology, Duke University School of Medicine, Durham, NC., Jensen RL; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA., Pantaleo G; Division of Immunology and Allergy, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Lausanne, Switzerland., Ding S; EuroVacc Foundation, Lausanne, Switzerland., Koutsoukos M; GlaxoSmithKline, Wavre, Belgium., Hosseinipour MC; University of North Carolina at Chapel Hill, Chapel Hill, NC.; UNC Project-Malawi, Lilongwe, Malawi., Van Der Meeren O; GlaxoSmithKline, Rixensart, Belgium; and., Gilbert PB; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA., Ferrari G; Center for Human Systems Immunology, Departments of Surgery, Molecular Genetics and Microbiology, and Immunology, Duke University School of Medicine, Durham, NC., Andersen-Nissen E; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA.; Cape Town HVTN Immunology Laboratory, Cape Town, South Africa., McElrath MJ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA., Tomaras GD; Center for Human Systems Immunology, Departments of Surgery, Molecular Genetics and Microbiology, and Immunology, Duke University School of Medicine, Durham, NC., Gray GE; South African Medical Research Council, Tygerberg, South Africa., Corey L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA., Kublin JG; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA.
Publikováno v:
Journal of acquired immune deficiency syndromes (1999) [J Acquir Immune Defic Syndr] 2024 Aug 01; Vol. 96 (4), pp. 350-360. Date of Electronic Publication: 2024 Jun 21.